« Previous
Next »
Advances in Chronic Kidney Disease
Volume 17, Issue 4
, Pages
e17-e26
, July 2010
Health-Related Quality of Life in Hypertension, Chronic Kidney Disease, and Coexistent Chronic Health Conditions
-
(A) Mean change in SF-36 Physical Health Component Scores by drug group (top left) and blood pressure goal (bottom left). (B) Mean change in SF-36 Mental Health Component Scores by drug group (top rig
(A) Mean change in SF-36 Physical Health Component Scores by drug group (top left) and blood pressure goal (bottom left). (B) Mean change in SF-36 Mental Health Component Scores by drug group (top right) and blood pressure goal (bottom right). Low goal: Mean arterial pressure 92 mm Hg or lower. Usual goal: Mean arterial pressure 102 to 107 mm Hg.
-
Changes in score in the individual items from the Diabetes Symptom Checklist. Patients with hypertension and type 2 diabetes treated with carvedilol reported a lower perceived burden of diabetes-relatChanges in score in the individual items from the Diabetes Symptom Checklist. Patients with hypertension and type 2 diabetes treated with carvedilol reported a lower perceived burden of diabetes-related symptoms than those treated with metoprolol.
This work was supported by NIH DK66006 and DK77785 (Unruh). Dr. Unruh also receives grant support from the Paul Teschan Research Fund, Norman Coplon Research Award, and the Baxter Extramural Grant Program. Dr. Unruh serves on the Medical Advisory Board for Baxter Healthcare.
PII: S1548-5595(10)00067-4
doi: 10.1053/j.ackd.2010.04.002
© 2010 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Advances in Chronic Kidney Disease
Volume 17, Issue 4
, Pages
e17-e26
, July 2010
